Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03872518 · ClinicalTrials.gov registry record
A Prospective Case Series Analysis of Initial Users of the Urovac Device
A clinical trial of Incontinence, Urinary, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT03872518: Completed study of Incontinence, Urinary, sponsored by Cedars-Sinai Medical Center.
NCT03872518 is a study of Incontinence, Urinary that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 10 participants, below the 177-participant average among 3 other Incontinence, Urinary trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03872518, a study of Incontinence, Urinary, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
To document usage of the Urovac device among 30 initial users of the device in an acute rehabilitation facility, with analysis of whether and how patients benefitted, challenges encountered, and how benefits and challenges varied by patient type.
Primary Outcome
Patient satisfaction with the Urovac device after two-hour use of the device, as measured by the statement: "I would recommend it to someone in a similar situation." The 5-point scale goes from 1-5, with 1 being "strongly disagree," 2 being "somewhat disagree," 3 being "neither agree nor disagree," 4 being "somewhat agree," and 5 being "strongly agree."
Conditions Studied
Interventions
- DEVICE Urovac
Study Locations (1)
California
- California Rehabilitation Institute - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-04-17 |
| Est. Completion | 2022-09-30 |
What the finished NCT03872518 record still lists
NCT03872518 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 177-participant average among 3 other Incontinence, Urinary trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Incontinence, Urinary appearing as the primary indexed condition, and to 1 intervention - of which Urovac is the first listed.
NCT03872518 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03872518 about?
NCT03872518 is a clinical study titled "A Prospective Case Series Analysis of Initial Users of the Urovac Device". To document usage of the Urovac device among 30 initial users of the device in an acute rehabilitation facility, with analysis of whether and how patients benefitted, challenges encountered, and how benefits and challenges varied by patient type.
What is the current status of trial NCT03872518?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-04-17. Estimated completion is 2022-09-30.
What conditions does trial NCT03872518 study?
This clinical trial studies the following conditions: Incontinence, Urinary.
What interventions are being tested in trial NCT03872518?
The interventions under investigation include: Urovac (DEVICE).
Who is sponsoring clinical trial NCT03872518?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03872518 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Incontinence, Urinary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
-
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
RECRUITING · Phase 4
-
TReating Incontinence for Underlying Mental and Physical Health
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI